Living with oral cancer: epidemiology with particular reference to prevalence and life-style changes that influence survival
- PMID: 20403722
- DOI: 10.1016/j.oraloncology.2010.02.015
Living with oral cancer: epidemiology with particular reference to prevalence and life-style changes that influence survival
Abstract
This review presents data on incidence, mortality, survival and trends on cancers of the lip, oral cavity and oropharynx using available recent data sources around the world. Oral and pharyngeal cancer, grouped together is the sixth most common cancer in the world. The review focuses primarily on prevalence of people still alive after an oral cancer diagnosis. In the world, there is close to a three quarter of a million people who previously had oral cancer and alive at 5years after diagnosis. The proportion alive at 5years is lower in less developed countries compared to earlier years. Within in Europe highest prevalence at 5years is seen in Western Europe. Our prevention strategies for this high risk group should include offering smoking cessation and other risk reduction measures. Smoking cessation in particular improves prognostic outcomes reducing the risk of secondary disease by approximately 2-3-fold.
Copyright 2010 Elsevier Ltd. All rights reserved.
Similar articles
-
Global epidemiology of oral and oropharyngeal cancer.Oral Oncol. 2009 Apr-May;45(4-5):309-16. doi: 10.1016/j.oraloncology.2008.06.002. Epub 2008 Sep 18. Oral Oncol. 2009. PMID: 18804401 Review.
-
The Health System and Policy Implications of Changing Epidemiology for Oral Cavity and Oropharyngeal Cancers in the United States From 1995 to 2016.Epidemiol Rev. 2017 Jan 1;39(1):132-147. doi: 10.1093/epirev/mxw001. Epidemiol Rev. 2017. PMID: 28402398 Review.
-
Incidence rates and trends of lip, oral and oro-pharyngeal cancers in Portugal.J Oral Pathol Med. 2013 Apr;42(4):345-51. doi: 10.1111/jop.12010. Epub 2012 Oct 4. J Oral Pathol Med. 2013. PMID: 23034073
-
Epidemiology of cancer from the oral cavity and oropharynx.Eur J Gastroenterol Hepatol. 2011 Aug;23(8):633-41. doi: 10.1097/MEG.0b013e3283484795. Eur J Gastroenterol Hepatol. 2011. PMID: 21654320 Review.
-
[Prevalence of cancer of the oral cavity and oropharynx].Acta Otorhinolaryngol Ital. 1990;10 Suppl 27:31-40. Acta Otorhinolaryngol Ital. 1990. PMID: 2392932 Italian.
Cited by
-
Oral cancer in India continues in epidemic proportions: evidence base and policy initiatives.Int Dent J. 2013 Feb;63(1):12-25. doi: 10.1111/j.1875-595x.2012.00131.x. Epub 2012 Dec 13. Int Dent J. 2013. PMID: 23410017 Free PMC article. Review.
-
Tumour associated tissue eosinophilia as a predictor of locoregional recurrence in oral squamous cell carcinoma.J Clin Exp Dent. 2015 Feb 1;7(1):e1-6. doi: 10.4317/jced.51610. eCollection 2015 Feb. J Clin Exp Dent. 2015. PMID: 25810818 Free PMC article.
-
miR-509 inhibits cancer stemness properties in oral carcinomas via directly targeting PlK1.J Dent Sci. 2022 Apr;17(2):653-658. doi: 10.1016/j.jds.2021.09.028. Epub 2021 Oct 8. J Dent Sci. 2022. PMID: 35756764 Free PMC article.
-
DUB3 Facilitates Growth and Inhibits Apoptosis Through Enhancing Expression of EZH2 in Oral Squamous Cell Carcinoma.Onco Targets Ther. 2020 Feb 18;13:1447-1460. doi: 10.2147/OTT.S230577. eCollection 2020. Onco Targets Ther. 2020. PMID: 32110043 Free PMC article.
-
In Vitro Anti-tumor Effects of Photodynamic Therapy on Oral Squamous Cell Carcinoma: A Review.J Lasers Med Sci. 2022 Nov 20;13:e49. doi: 10.34172/jlms.2022.49. eCollection 2022. J Lasers Med Sci. 2022. PMID: 37041780 Free PMC article. Review.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical